% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Rajtmajerova:304274,
author = {M. Rajtmajerova and F. Ambrozkiewicz and V. Hlavac and A.
Trailin and L. Cervenkova and J. Bruha and S. Susova and P.
Soucek and P. Vodicka and L. Vodickova and O. Kubecek and S.
Filip and V. R. Mallela and W. Ye and F. Zitricky and V.
Liska and K. Hemminki$^*$},
title = {{G}enetic differences between primary colorectal cancer and
its paired synchronous and metachronous metastases.},
journal = {International journal of cancer},
volume = {nn},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2025-01815},
pages = {nn},
year = {2025},
note = {#LA:Z999# / epub},
abstract = {As the second most deadly cancerous disease worldwide,
colorectal cancer (CRC) stands in the center of scientific
interest in hope to develop novel approaches for precise
diagnostics and prognosis determination. Metastatic disease
remains the main cause of CRC mortality. To investigate the
underlying genetic differences between CRC patients with
synchronous and metachronous liver metastases, we performed
whole-exome sequencing of 210 patient samples using
formalin-fixed paraffin-embedded samples from primary tumors
and the paired liver metastatic tissue. The analyses
included types and levels of mutations and copy number
variation. APC and TP53 were the most commonly mutated genes
in all samples with differing frequency between primary CRC
(both $50\%)$ and its metachronous metastasis (both $64\%).$
While MPDZ gene mutations were restricted to primary tumors
that developed metachronous metastases only, mutations in
VCAN, MTCL1, MDN1, SHROOM2, SPEG, and GLI2 were more
prevalent in primary tumors giving rise to synchronous
metastases. FBN1 mutations were unique to synchronous liver
metastatic tissue. Analysis of genetic interactions revealed
different associations between mutated genes in patients
with tumors of different chronicity, including driver genes
such as TP53, which was associated with APC in synchronous
patients, while in primary tumors with metachronous
metastases it co-occurs with mutations in NBPF11 and
PRAMEF15, respectively. The results suggest that distinct
tumor progression pathways account for different chronicity
outcomes further affecting patients' survival. However,
larger studies are needed incorporating transcriptomic and
epigenomic data to shed further light on the mechanistic
chain from mutations to downstream gene expression
regulation.},
keywords = {WES (Other) / colorectal cancer (Other) / metachronous
liver metastasis (Other) / synchronous liver metastasis
(Other) / whole‐exome sequencing (Other)},
cin = {Z999},
ddc = {610},
cid = {I:(DE-He78)Z999-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40884237},
doi = {10.1002/ijc.70116},
url = {https://inrepo02.dkfz.de/record/304274},
}